San Diego, CA · Founded 2013 · Privately Held (backing)
Developer of corneal therapeutics designed to facilitate the treatment of ophthalmic diseases. Trefoil Therapeutics is based in San Diego, CA and was founded in 2013. It was valued at $59.5 million at its later-stage round in May 2025, the last priced event on record. It has raised $49.7 million across 4 recorded rounds; the latest was a $4.6 million seed round in Apr 2025.
PMV mark · valuation
$59.5M
Oct 2026
Priced at
its later-stage round
May 2025
Total raised
$49.7M
Last round
Seed Round
Apr 2025
Cap table — not yet on record
Trefoil Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Trefoil Therapeutics with a free account
·The complete investor list: 12 names
·Watch Trefoil Therapeutics: the Monday email on marks, rounds and moves
Where does Trefoil Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Trefoil Therapeutics's 4 recorded funding rounds.
Trefoil Therapeutics Cap Table & Share Classes | Premier Alternatives
